Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C. Tammemägi, Stephen Lam, Kazuhiro Yasufuku et al.|The Lancet Oncology|2017Cited by 222
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stephen Lam, Stuart Peacock et al.|Journal of Thoracic Oncology|2017Cited by 142
Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinomaKatey S.S. Enfield, Wan L. Lam, Erin A. Marshall et al.|Nature Communications|2019Cited by 73
Resource Utilization and Costs during the Initial Years of Lung Cancer Screening with Computed Tomography in CanadaSonya Cressman, Stuart Peacock, Stephen Lam et al.|Journal of Thoracic Oncology|2014Cited by 51
OA 15.01 Lung Cancer Screening: Participant Selection by Risk Model – the Pan-Canadian StudyMartin C. Tammemägi, S. Lam, Heidi Schmidt et al.|Journal of Thoracic Oncology|2017Cited by 0